+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

North America PCR Technologies Market Forecast to 2030 - Regional Analysis - by Technology, Offerings, Application and End User

  • PDF Icon

    Report

  • 140 Pages
  • July 2024
  • Region: North America
  • The Insight Partners
  • ID: 6006613
UP TO OFF until Dec 31st 2024
The North America PCR technologies market is expected to grow from US$ 5.07 billion in 2022 to US$ 9.63 billion by 2030. It is estimated to record a CAGR of 8.3%from 2022 to 2030.

Advancements in PCR Technologies Fuel North America PCR Technologies Market

The advantages of PCR such as exquisite sensitivity, relative simplicity, and cost-effectiveness have tremendously added to its popularity in the past years. The PCR technology has evolved significantly, resulting in more specific workflows for a wide variety of applications. The use of PCR technology is being explored into several nonconventional applications, making molecular diagnosis easier and faster. Advancements in dPCR and RT-PCR are used to diagnose diseases, identify viruses and bacteria, and aid forensic investigations. Researchers are trying to reduce test time using some nanomaterials.

In March 2023, the Center for Augmented Safety System with Intelligence, Sensing of the Korea Institute of Science and Technology (KIST) announced the development of an ultrafast PCR technology. The development project was led by Dr. Sang Kyung Kim (Director) and Dr. Seungwon Jung's research team. The ultrafast PCR reduces the test duration by 10 times compared to the previous tests by utilizing photothermal nanomaterials. The diagnostic performance of the new method is comparable to existing test methods, and it can be finished in 5 minutes. In January 2021, Danaher Corporation announced that Health Canada issued a medical device license to Cepheid for Xpert Xpress SARS-CoV-2/Flu/RSV.

A few of the technological advancements by companies in the PCR technologies market are as given, In March 2021, PCR Biosystems announced the launch of its IsoFast Bst polymerase reagents, which support sensitive, robust, and rapid amplification of RNA and DNA, enabling faster testing procedures. In October 2021, Thermo Fisher Scientific introduced the Applied Biosystem Quantstudio Absolute Q-Digital PCR System, the first fully integrated dPCR system designed to deliver highly accurate and consistent genetic analysis. The company claims that the product generates research results within 90 minutes. In May 2022, Bio-Rad Laboratories, Inc. introduced its CFX Duet Real-Time PCR System in selected countries that accept the CE Mark.

The system is intended to support researchers in developing singleplex and duplex qPCR assays. In November 2022, PCR Biosystems launched new qPCR reagent mixes-Clara Probe Mix, Clara Probe 1-Step Mix, and Clara HRM Mix. In November 2022, Cepheid launched the Xpert Xpress MVP multiplex PCR test. The test helps detect DNA from organisms that are associated with three distinct conditions, namely, bacterial vaginosis (BV), trichomoniasis, and vulvovaginal candidiasis, from a single sample, aiding in more precise diagnosis and supporting accurate antibiotic treatment regimens. Thus, such advancements are expected to bring new trends into the PCR technologies market in the coming years.

North America PCR Technologies Market Overview

The North America PCR technologies market is segmented into the US, Canada, and Mexico. Market growth in this region is attributed to the increased demand for innovative products from bioanalytical instrument manufacturers and PCR companies, the presence of key market players, and extensive R&D conducted across various academic and research institutes. In addition, the well-known practice of adopting medical devices in healthcare operations to improve quality and reduce costs also benefits the PCR technologies market in the US and other North American countries.

An upsurge in the acceptance and adoption of gene synthesis and editing tools such as CRISPR and PCR in research and therapeutics necessitates assays that aid in rapid quantification, alterations, and observation. The emergence of digital PCR in the form of droplet digital PCR offers new opportunities for screening, providing superior sensitivity and easy adaptability. The US is seeking significant funding from public and private organizations to encourage investments in advanced research methodologies. For instance, the International Centre for Genetic Engineering and Biotechnology aims to stimulate collaborative research in the member states.

It receives funds through the Collaborative Research Programme (CRP) that aims to address original scientific problems of relevance and interest. Advancements in biotechnology that depend on PCR techniques to help improve human health, animal welfare, and food security. The US Food and Drug Administration (USFDA) is committed to ensuring the safety of biotechnology products.

The US actively participates in various research groups and organizations to conduct scientific conferences, workshops, and events that help exchange the trends and latest research studies based on PCR within different geographies. Therefore, the country's active involvement is also one of the factors driving the growth of the PCR technologies market.

North America PCR Technologies Market Segmentation

The North America PCR technologies market is segmented into technology, offerings, application, end user, and country.
  • Based on technology, the North America PCR technologies market is segmented into real time PCR, conventional PCR, reverse transcription, digital PCR, multiplex RTPCR, hot start PCR, and others. The real time PCR segment held the largest share of North America PCR technologies market in 2022.
  • In terms of offerings, the North America PCR technologies market is categorized into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share of North America PCR technologies market in 2022. Further, reagents & consumables segment are categorized into reagents, vials size, and other consumables. Furthermore, vials size is segmented into 0.2ml to 2ml, 0.1 ml to 0.3 ml, 2 ml to 5ml, and other vials. Additionally, instruments segment is bifurcated into benchtop PCR and portable thermocyclers/PCR.
  • By application, the North America PCR technologies market is segmented into gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point of care diagnostic application, environmental application, and others. The gene expression analysis segment held the largest share of North America PCR technologies market in 2022.
  • Based on end user, the North America PCR technologies market is categorized into hospitals & diagnostic centres, pharmaceutical & biotechnology companies, academic institutes & research laboratories, and others. The hospitals & diagnostic centres segment held the largest share of North America PCR technologies market in 2022.
  • By country, the North America PCR technologies market has been categorized into the US, Canada, and Mexico. The US dominated the North America PCR technologies market in 2022.
Thermo Fisher Scientific Inc, Promega Corp, QIAGEN NV, bioMerieux SA, Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Becton Dickinson and Co, Atila Biosystems Inc, Takara Bio Inc, Standard Bio Tools Inc, Agilent Technologies Inc, Visby Medical Inc, and Ellume Ltd are some of the leading companies operating in the North America PCR technologies market.

Table of Contents

1. Introduction
1.1 Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America PCR Technologies Market - Key Industry Dynamics
4.1 PCR Technologies Market - Key Industry Dynamics
4.2 Market Drivers
4.2.1 Rising Prevalence of Genetic and Infectious Diseases
4.2.2 Surging Investments and Funds Availability for PCR Technologies
4.3 Market Restraints
4.3.1 High Costs of PCR Systems and Availability of Alternative Assays
4.4 Market Opportunities
4.4.1 Increasing Demand for POC Testing
4.5 Future Trends
4.5.1 Advancements in PCR Technologies
4.6 Impact of Drivers and Restraints:
5. PCR Technologies Market - North America Market Analysis
5.1 PCR Technologies Market Revenue (US$ Million), 2020 - 2030
6. North America PCR Technologies Market Analysis - By Technology
6.1 Overview
6.2 Real Time PCR
6.2.1 Overview
6.2.2 Real Time PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Conventional PCR
6.3.1 Overview
6.3.2 Conventional PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Reverse Transcription PCR
6.4.1 Overview
6.4.2 Reverse Transcription PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.5 Digital PCR
6.5.1 Overview
6.5.2 Digital PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.6 Multiplex RT PCR
6.6.1 Overview
6.6.2 Multiplex RT PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.7 Hot Start PCR
6.7.1 Overview
6.7.2 Hot Start PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.8 Others
6.8.1 Overview
6.8.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
7. North America PCR Technologies Market Analysis - By Offerings
7.1 Overview
7.2 PCR Technologies Market Revenue Share, by Offerings 2022 & 2030 (%)
7.3 Reagents and Consumables
7.3.1 Overview
7.3.2 Reagents and Consumables Market, Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
7.3.2.1.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)
7.4.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
7.5 Software and Services
7.5.1 Overview
7.5.2 Software and Services Market, Revenue and Forecast to 2030 (US$ Million)
8. North America PCR Technologies Market Analysis - By Application
8.1 Overview
8.2 PCR Technologies Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Gene Expression Analysis
8.3.1 Overview
8.3.2 Gene Expression Analysis Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Genetic Sequencing
8.4.1 Overview
8.4.2 Genetic Sequencing Market, Revenue and Forecast to 2030 (US$ Million)
8.5 Genotyping
8.5.1 Overview
8.5.2 Genotyping Market, Revenue and Forecast to 2030 (US$ Million)
8.6 Nucleic Acid Synthesis
8.6.1 Overview
8.6.2 Nucleic Acid Synthesis Market, Revenue and Forecast to 2030 (US$ Million)
8.7 Standard Validation
8.7.1 Overview
8.7.2 Standard Validation Market, Revenue and Forecast to 2030 (US$ Million)
8.8 Point of Care Diagnostics
8.8.1 Overview
8.8.2 Point of Care Diagnostics Market, Revenue and Forecast to 2030 (US$ Million)
8.9 Environmental Application
8.9.1 Overview
8.9.2 Environmental Application Market, Revenue and Forecast to 2030 (US$ Million)
8.10 Others
8.10.1 Overview
8.10.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
9. North America PCR Technologies Market Analysis - By End User
9.1 Overview
9.2 PCR Technologies Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals and Diagnostic Centers
9.3.1 Overview
9.3.2 Hospitals and Diagnostic Centers Market, Revenue and Forecast to 2030 (US$ Million)
9.4 Academia and Research Institutes
9.4.1 Overview
9.4.2 Academia and Research Institutes Market, Revenue and Forecast to 2030 (US$ Million)
9.5 Pharmaceutical and Biotechnology Companies
9.5.1 Overview
9.5.2 Pharmaceutical and Biotechnology Companies Market, Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
10. North America PCR Technologies Market - Country Analysis
10.1 North America: PCR Technologies Market
10.1.1 Overview
10.1.2 North America PCR Technologies Market Revenue and Forecast and Analysis - By Country
10.1.2.1 United States
10.1.2.1.1 Overview
10.1.2.2 United States PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.2.1 United States PCR Technologies Market Breakdown by Technology
10.1.2.2.2 United States PCR Technologies Market Breakdown by Offerings
10.1.2.2.2.1 United States PCR Technologies Market Breakdown by Instruments
10.1.2.2.2.2 United States PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.2.2.2.1 United States PCR Technologies Market Breakdown by Vial Size
10.1.2.2.3 United States PCR Technologies Market Breakdown by Application
10.1.2.2.4 United States PCR Technologies Market Breakdown by End User
10.1.2.3 Canada
10.1.2.3.1 Overview
10.1.2.4 Canada PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.4.1 Canada PCR Technologies Market Breakdown by Technology
10.1.2.4.2 Canada PCR Technologies Market Breakdown by Offerings
10.1.2.4.2.1 Canada PCR Technologies Market Breakdown by Instruments
10.1.2.4.2.2 Canada PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.4.2.2.1 Canada PCR Technologies Market Breakdown by Vial Size
10.1.2.4.3 Canada PCR Technologies Market Breakdown by Application
10.1.2.4.4 Canada PCR Technologies Market Breakdown by End User
10.1.2.5 Mexico
10.1.2.5.1 Overview
10.1.2.6 Mexico PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.6.1 Mexico PCR Technologies Market Breakdown by Technology
10.1.2.6.2 Mexico PCR Technologies Market Breakdown by Offerings
10.1.2.6.2.1 Mexico PCR Technologies Market Breakdown by Instruments
10.1.2.6.2.2 Mexico PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.6.2.2.1 Mexico PCR Technologies Market Breakdown by Vial Size
10.1.2.6.3 Mexico PCR Technologies Market Breakdown by Application
10.1.2.6.4 Mexico PCR Technologies Market Breakdown by End User
11. PCR Technologies Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the PCR Technologies Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Thermo Fisher Scientific Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Promega Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 QIAGEN NV
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 bioMerieux SA
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Hoffmann-La Roche Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Bio-Rad Laboratories Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Becton Dickinson and Co
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Atila Biosystems Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Takara Bio Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Standard Biotools Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Agilent Technologies Inc
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
12.12 Visby Medical Inc
12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 Financial Overview
12.12.5 SWOT Analysis
12.12.6 Key Developments
12.13 Ellume Ltd
12.13.1 Key Facts
12.13.2 Business Description
12.13.3 Products and Services
12.13.4 Financial Overview
12.13.5 SWOT Analysis
12.13.6 Key Developments
13. Appendix
13.1 About The Publisher
13.2 Glossary of Terms
LIST OF TABLES
Table 1. PCR Technologies Market Segmentation
Table 2. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Technology
Table 3. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Offerings
Table 4. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
Table 5. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
Table 6. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
Table 7. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Application
Table 8. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By End User
Table 9. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 10. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 11. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 12. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 13. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 14. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 15. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 16. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 17. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 18. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 19. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 20. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 21. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 22. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 23. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 24. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 25. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 26. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 27. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 28. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 29. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 30. Recent Inorganic Growth Strategies in the PCR Technologies Market
Table 31. Recent Organic Growth Strategies in the PCR Technologies Market
Table 32. Glossary of Terms, PCR Technologies Market
LIST OF FIGURES
Figure 1. PCR Technologies Market Segmentation, By Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. PCR Technologies Market Revenue (US$ Million), 2020 - 2030
Figure 4. PCR Technologies Market Share (%) - By Technology, 2022 and 2030
Figure 5. Real Time PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Conventional PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Reverse Transcription PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 8. Digital PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 9. Multiplex RT PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 10. Hot Start PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. PCR Technologies Market Share (%) - By Offerings, 2022 and 2030
Figure 13. Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. Instruments Market Revenue and Forecasts to 2030 (US$ Million)
Figure 15. Software and Services Market Revenue and Forecasts to 2030 (US$ Million)
Figure 16. PCR Technologies Market Share (%) - By Application, 2022 and 2030
Figure 17. Gene Expression Analysis Market Revenue and Forecasts to 2030 (US$ Million)
Figure 18. Genetic Sequencing Market Revenue and Forecasts to 2030 (US$ Million)
Figure 19. Genotyping Market Revenue and Forecasts to 2030 (US$ Million)
Figure 20. Nucleic Acid Synthesis Market Revenue and Forecasts to 2030 (US$ Million)
Figure 21. Standard Validation Market Revenue and Forecasts to 2030 (US$ Million)
Figure 22. Point of Care Diagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 23. Environmental Application Market Revenue and Forecasts to 2030 (US$ Million)
Figure 24. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 25. PCR Technologies Market Share (%) - By End User, 2022 and 2030
Figure 26. Hospitals and Diagnostic Centers Market Revenue and Forecasts to 2030 (US$ Million)
Figure 27. Academia and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
Figure 28. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
Figure 29. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 30. North America: PCR Technologies Market, by Key Country - Revenue (2022) (US$ Million)
Figure 31. North America PCR Technologies Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 32. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 33. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 34. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 35. Growth Strategies in the PCR Technologies Market

Companies Mentioned

  • Thermo Fisher Scientific Inc
  • Promega Corp
  • QIAGEN NV
  • bioMerieux SA
  • Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Becton Dickinson and Co
  • Atila Biosystems Inc
  • Takara Bio Inc
  • Standard BioTools Inc
  • Agilent Technologies Inc
  • Visby Medical Inc
  • Ellume Ltd